Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-04-18 00:00:00 ET · period of report 2023-04-17 · accession 0001104659-23-046897 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-18 | 2023-04-17 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | S - Sale+OE | $42.35 | -5,632 | 105.1K | -5% | -$238.5K |
| D | 2023-04-18 | 2023-04-17 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $13.35 | +5,632 | 110.8K | +5% | +$75.2K |
| D | 2023-04-18 | 2023-04-17 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $0.00 | -5,632 | 29.0K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-17 | S | D | 5,632 | $42.35 | 105,148 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-17 | M | A | 5,632 | $13.35 | 110,780 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2023-04-17 | M | D | 5,632 | $0.00 | 28,990 | D | $13.35 · — to 2027-03-16 | 5,632 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |